Nemaura Medical adds independent director
Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Nemaura Medical Inc. added Thomas Moore to the company's board as an independent director.
Moore, who has worked with accountancy firms Grant Thornton and KPMG, will also serve as a member of the board's audit, nominating and corporate governance and compensation committees.
